Royalty Pharma (RPRX)
(Delayed Data from NSDQ)
$28.41 USD
-0.35 (-1.22%)
Updated May 3, 2024 04:00 PM ET
After-Market: $28.40 -0.01 (-0.04%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth B Momentum C VGM
Industry / Sector Report
Industry : Financial - Miscellaneous Services
Zacks Industry Rank
Top 40% (100 out of 252)Zacks Sector Rank
Bottom 38% (10 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.21 | 1.69 | 9.99 |
Current Quarter Estimate | 0.96 | 7.09 | 57.00 |
Year Ago Quarter Estimate | 1.60 | 4.55 | 52.54 |
Next Quarter Estimate | 0.90 | 6.89 | 61.00 |
Next Year Estimate | 4.32 | 34.78 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -12.03 | 9.40 | 15.67 |
Next Year | 9.37 | 13.60 | 9.31 |
Last 5 Years | NA | 5.80 | 8.10 |
Next 5 Years | NA | 21.00 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 6.47 | 13.52 |
Price/Book (MRQ) | 1.68 | 1.01 |
Price/Cash Flow (MRFY) | 6.22 | 8.10 |
Dividend Yield | 2.96% | 0.00% |
Net Profit Margin (TTM) | 48.22% | 8.33% |
Return on Equity (TTM) | 26.93% | 11.47% |
Debt to Equity (MRQ) | NA | 33.12 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.